AMRI CEO to Present at the 12th Annual Needham Healthcare Conference

     AMRI CEO to Present at the 12th Annual Needham Healthcare Conference

  PR Newswire

  ALBANY, New York, April 23, 2013

ALBANY, New York, April 23, 2013 /PRNewswire/ --AMRI (NASDAQ: AMRI) announced
today that AMRI Chairman, President and Chief Executive Officer Thomas E.
D'Ambra, Ph.D. will present at the 12th Annual Needham Healthcare Conference
on Tuesday, April 30, 2013 at 12:50 p.m. ET.

(Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO )

A webcast of the corporate presentation will be available to investors and
interested parties by accessing the company's website at www.amriglobal.com .
This webcast will be archived for 90 days following the live presentation.

About AMRI

Albany Molecular Research, Inc. (AMRI) is a global contract research and
manufacturing organization offering customers fully integrated drug discovery,
development and manufacturing services. For over 21 years, AMRI has
demonstrated its adaptability as the pharmaceutical and biotechnology
industries have undergone tremendous change in response to multiple
challenges. This experience, a track record of success and locations in the
United States, Europe and Asia now provides our customers with SMARTSOURCING™,
a full range of value-added opportunities providing customers informed
decision-making, enhanced efficiency and more successful outcomes at all
stages of the pipeline. AMRI has also successfully partnered R&D programs and
is actively seeking to out-license its remaining programs for further
development. For more information about AMRI, please visit our website at
www.amriglobal.com or follow us on Twitter (@amriglobal).

Website: http://www.amriglobal.com
Contact: Investors - Michael Nolan, AMRI Chief Financial Officer,
+1-518-512-2261, Media - Gina Monari, AMRI Communications, +1-518-512-2512
 
Press spacebar to pause and continue. Press esc to stop.